About the Joint Institute for Translational and Clinical Research
In 2010, the University of Michigan Medical School and Peking University Health Science Center (PUHSC) signed an unprecedented agreement to establish a Joint Institute (JI) for Translational & Clinical Research. Each institution contributed $7 million for the 2010 launch and both renewed their financial commitment with repeat $7 million investments in 2015, securing the JI and the international collaboration for years to come.
The Joint Institute's research programs focus on four pervasive medical conditions: cardiovascular disease, liver disease, pulmonary disease, and renal disease. In each of these areas, panels of experts from both universities have identified promising clinical and translational research studies that will be conducted jointly by teams at each university. Through this partnership, UMHS and PUHSC hope to enable scientists to translate basic research more quickly and efficiently into medical practice and improve outcomes for patients in the U.S., in China, and around the world.
To ensure highly effective collaboration, the JI provides infrastructure “cores” to work through potential issues and concerns, including human subject protection, biorepository and biomedical informatics, as well as the science of collaboration. In addition to clinical and translational research initiatives, the Joint Institute also promotes the exchange of ideas between the two universities by hosting joint symposia and lectures; establishing an exchange program for faculty members, medical residents, fellows, and students; sharing academic information and publications; and conducting joint research on the science of collaboration.
Amy Huang, M.D., MHSA
Director for China Programs, Global REACH
Adjunct Clinical Assistant Professor of Cardiovascular Medicine, Department of Internal Medicine
Victor Vaughn Building, Room 242
1111 East Catherine Street
Ann Arbor, MI 48109-2054
Phone: (734) 763-6461, Fax: (734) 615-6300